Regulatory
The India — Central Drugs Standard Control Organisation issued a public advisory circular, dated September 21, warning against the indiscriminate, repeated or prolonged use of painkillers, particularly non-steroidal anti-inflammatory drugs (NSAIDs), and antibiotics, citing a…
Impact: The apex drug regulator is the primary issuer of the advisory, mandating prescription-only sales and supervised use of NSAIDs and antibiotics. Its action strengthens its regulatory stance but imposes compliance burdens on pharma and pharmacy retail.
Sep 22, 2026 · 20 articles